The Effect of Neurofeedback and Cranial Electrotherapy on Immune Function Within a Group of HIV+ Subjects: A Controlled Study
AbstractThis study investigated the effects of neurofeedback and cranial electrotherapy on a group of subjects (n¼40) with the human immunodeficiency virus (HIV) over a 16-week period. Subjects were randomly assigned to one of four groups: neurofeedback only (n¼10), cranial electrotherapy only (n¼10), combined neurofeedback and cranial electrotherapy (n¼10), and a waitlist control group (n¼10). After 16-weeks, CD4 counts were significantly greater than controls for the neurofeedback group and combined group. There was no significant
change in CD4 count for the cranial electrotherapy group. Results of this pilot study suggest that neurofeedback may improve immune function and warrants further investigation.
© International Society for Neurofeedback and Research (ISNR), all rights reserved. This article (the “Article”) may be accessed online from ISNR at no charge. The Article may be viewed online, stored in electronic or physical form, or archived for research, teaching, and private study purposes. The Article may be archived in public libraries or university libraries at the direction of said public library or university library. Any other reproduction of the Article for redistribution, sale, resale, loan, sublicensing, systematic supply, or other distribution, including both physical and electronic reproduction for such purposes, is expressly forbidden. Preparing or reproducing derivative works of this article is expressly forbidden. ISNR makes no representation or warranty as to the accuracy or completeness of any content in the Article. From 1995 to 2013 the Journal of Neurotherapy was the official publication of ISNR (www. Isnr.org); on April 27, 2016 ISNR acquired the journal from Taylor & Francis Group, LLC. In 2014, ISNR established its official open-access journal NeuroRegulation (ISSN: 2373-0587; www.neuroregulation.org).